R&D

Cancer R&D tips the scales at the FDA as active INDs climb to record high
Endpoints
Wed, 12/6/17 - 09:58 am
cancer
R&D
INDs
FDA
Bayer decides it's time to stick research and development together
BioPharma Dive
Fri, 12/1/17 - 11:47 am
Bayer
R&D
reorganization
After R&D spree, Bayer changes up research unit as Busch heads for the door
Fierce Biotech
Thu, 11/30/17 - 11:37 am
R&D
Bayer
reorganization
J&J-led coalition launches a landmark efficacy study for an HIV mosaic vaccine
Endpoints
Thu, 11/30/17 - 09:46 am
JNJ
HIV
vaccines
R&D
mosaic vaccine
Imbokodo
HVTN 705/HPX2008
These 10 medtech companies care a lot about research
Medical Design and Outsourcing
Thu, 11/30/17 - 09:35 am
devices
R&D
Cochlear
Biomerieux
Accuray
Analogic
Edwards Lifesciences
Abiomed
Insulet
AtriCure
Spectranetics
DexCom
Regeneron and Decibel aren’t just collaborating: They want to create a whole new partnering model
Endpoints
Wed, 11/29/17 - 09:57 pm
Regeneron
Decibel Therapeutics
R&D
Pharma’s broken business model: An industry on the brink of terminal decline
Endpoints
Tue, 11/28/17 - 10:44 am
pharma industry
R&D
Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul
Endpoints
Mon, 11/27/17 - 10:44 am
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
R&D
executives
Merck blueprints $1.3B research hub in a post-Brexit London, with 950 staffers
Endpoints
Mon, 11/27/17 - 09:08 am
Merck
London
R&D
drug development
Brexit
Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report
Endpoints
Fri, 11/24/17 - 11:36 am
Teva Pharmaceutical
R&D
layoffs
Kåre Schultz
Bayer AG taps PeptiDream in billion-dollar deal
Endpoints
Mon, 11/20/17 - 11:10 am
Bayer
R&D
Japan
PeptiDream
In the search for Alzheimer’s drugs, researchers must look beyond beta amyloid
Stat
Sun, 11/19/17 - 09:49 am
R&D
drug development
Alzheimer's disease
beta amyloid
Bill Gates
Merck strikes autoimmune deal with newly-emerged Cue
BioPharma Dive
Fri, 11/17/17 - 10:18 am
Merck
autoimmune disease
Cue Biopharma
R&D
drug development
Genentech inks $650M deal with protein degradation pioneer Arvinas
Endpoints
Wed, 11/15/17 - 11:10 am
Genentech
targeted protein degradation
Arvinas
R&D
GSK nabs Calico scientist Barron as new R&D head, Vallance quits
Yahoo/Reuters
Wed, 11/8/17 - 09:22 am
GSK
R&D
Calico Life Sciences
Amgen and Genentech are the latest drug makers to lay off workers
Stat
Sat, 11/4/17 - 07:23 pm
Amgen
Genentech
layoffs
R&D
drug manufacturing
Merck
drug reps
GSK R&D chief Vallance is out as its new CEO changes direction under a new crew
Endpoints
Fri, 11/3/17 - 10:40 am
GSK
R&D
restructuring
drug development
Pharma's betting big on China, but R&D boom still to come
BioPharma Dive
Mon, 10/30/17 - 11:22 pm
China
R&D
Single-source contracting could speed drug development
BioPharma Dive
Thu, 10/26/17 - 10:17 pm
drug development
R&D
CMOs
CROs
AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
Endpoints
Tue, 10/24/17 - 09:10 am
AbbVie
Alzheimer's disease
Alector
R&D

Pages